Stock Price Movement and Market Context
On 4 Mar 2026, Trident Texofab Ltd opened sharply lower by 4.99%, trading at Rs.67.74, which also represented the day’s intraday low. The stock has since remained at this level without recovering, indicating persistent selling pressure. This performance notably underperformed its sector, which declined by 2.95% on the same day, and the stock lagged the sector by 2.12% in relative terms.
The broader market environment showed some resilience, with the Sensex recovering 266.37 points after a gap down opening of 1,710.03 points, closing at 78,795.19, down 1.8%. However, Trident Texofab’s share price continued its downward trajectory, trading below all key moving averages – 5-day, 20-day, 50-day, 100-day, and 200-day – underscoring the prevailing bearish momentum.
Long-Term Performance and Valuation Metrics
Over the past year, Trident Texofab Ltd has delivered a negative return of 60.88%, a stark contrast to the Sensex’s positive 7.96% gain during the same period. The stock’s 52-week high was Rs.379, highlighting the extent of the decline. The company’s market capitalisation grade stands at 4, reflecting its micro-cap status within the Garments & Apparels sector.
Despite the steep price fall, the stock’s valuation metrics present a mixed picture. The company’s Return on Capital Employed (ROCE) remains modest at 7.4%, while the Enterprise Value to Capital Employed ratio is an attractive 1.6, suggesting the stock is trading at a discount relative to its capital base. Additionally, the Price/Earnings to Growth (PEG) ratio is 0.6, indicating that the stock’s price decline has outpaced its profit growth, which rose by 122.5% over the past year.
Turnaround taking shape! This Small Cap from NBFC sector just hit profitability with strong business fundamentals showing up. Catch it before the major breakout happens!
- - Recently turned profitable
- - Strong business fundamentals
- - Pre-breakout opportunity
Financial Health and Credit Metrics
Trident Texofab Ltd’s financial strength remains a concern. The company’s Debt to EBITDA ratio is elevated at 6.83 times, indicating a relatively high leverage level and a limited ability to service debt efficiently. This weak long-term fundamental strength is reflected in the company’s Mojo Score of 23.0 and a Mojo Grade of Strong Sell, which was downgraded from Sell on 3 Feb 2026.
Quarterly results for December 2025 showed net sales at Rs.25.74 crore, the lowest in recent periods, signalling subdued revenue generation. The company’s performance has been below par not only in the near term but also over longer horizons, underperforming the BSE500 index across 3 months, 1 year, and 3 years.
Shareholding and Market Position
The majority of Trident Texofab Ltd’s shares are held by non-institutional investors, which may contribute to the stock’s volatility and price sensitivity. The company operates within the Garments & Apparels industry, a sector that has seen mixed performance, with some indices such as NIFTY Realty and S&P BSE Realty also hitting 52-week lows on the same day.
Why settle for Trident Texofab Ltd? SwitchER evaluates this Garments & Apparels micro-cap against peers, other sectors, and market caps to find you superior investment opportunities!
- - Comprehensive evaluation done
- - Superior opportunities identified
- - Smart switching enabled
Technical and Market Indicators
The stock’s technical indicators remain weak, with prices consistently below all major moving averages, signalling a sustained downtrend. The 21-day consecutive decline is a notable streak, reflecting persistent selling pressure and a lack of short-term support levels. The gap down opening today further emphasises the negative sentiment surrounding the stock.
In contrast, the Sensex, while trading below its 50-day moving average, maintains a 50DMA above its 200DMA, suggesting a more stable medium-term market trend. This divergence highlights the stock-specific challenges faced by Trident Texofab Ltd within an otherwise recovering market environment.
Summary of Key Metrics
To summarise, Trident Texofab Ltd’s stock has reached a new 52-week low of Rs.67.74, reflecting a 65.81% decline over the last 21 trading days and a 60.88% loss over the past year. The company’s financial indicators reveal modest profitability growth but are overshadowed by high leverage and weak capital returns. The downgrade to a Strong Sell grade and the low Mojo Score underscore the cautious stance on the stock’s current fundamentals.
While the valuation metrics suggest the stock is trading at a discount relative to its capital employed and peers, the prevailing market and company-specific factors have contributed to the sustained downward pressure on the share price.
Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →
